Protocol DIVAT-Uro

Nantes University Hospital (NUH)

Status: Terminated

Conditions: Kidney Transplantation; Pancreas-kidney Transplantation

Treatments: Other: Capture data

Study type: Observational

Funder types: Other

Identifiers

NCT01280708

BRD/09/11-E

Details and patient eligibility

About

The aim of project DIVAT-URO (Données Informatisées et Validées en Transplantation - Urology) is to organize a thematic network in urology traced on NetWork DIVAT to supplement the medical and biological data of DIVAT existing cohort with parameters of surgical transplantation of kidney and pancreas. These data will concern the transplantation itself and the events and complications related to surgery occurring throughout the follow-up. The collection will involve patients in the cohort DIVAT and future patients. This project will allow us to have the sufficiency of surgical transplantation by increasing the quantity and quality of information gathered thus avoiding the biases commonly upbraided against the retrospective studies. Finally, by supplementing it with new parameters, it will strengthen the medical and scientific interest of the cohort DIVAT and will open new perspectives for clinical trials in surgery and work in epidemiology.Networking of urologists and the expansion of the base DIVAT would carry out research in epidemiology and factors that may play a role in the outcome of renal and pancreatic transplantation. It would also help to define good practices. The first study from the proposed network DIVAT-Uro is assessing the impact of vesico-ureteric reflux on the occurrence of urinary tract infections and effects on survival of the transplant in the recipient adult.

Enrollment: 1,616 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged over 18 years
• Patients received a kidney transplant or a simultaneous pancreas-kidney transplant
• Patients who read the newsletter and signed the consent form on the computerization of data

Exclusion criteria

• Patients aged under 18 years
• Patients who did not sign the consent form

Trial design

1,616 participants in 1 patient group

Capture data

Treatment:

Other: Capture data